...
首页> 外文期刊>Journal of microbiology, immunology, and infection: Wei mian yu gan ran za zhi >Occurrence and phenotypic detection of class A carbapenemases among Escherichia coli and Klebsiella pneumoniae blood isolates at a tertiary care center
【24h】

Occurrence and phenotypic detection of class A carbapenemases among Escherichia coli and Klebsiella pneumoniae blood isolates at a tertiary care center

机译:三级护理中心大肠埃希菌和肺炎克雷伯菌血液分离物中A类碳青霉烯酶的发生和表型检测

获取原文
获取原文并翻译 | 示例
           

摘要

Resistance to carbapenems is a significant therapeutic threat. The increasing frequency of car bapenemase enzymes among Gram-negative bacilli makes their early detection and differentiation urgent. Carbapenemases belonging to Class A are most commonly produced by members of family Enterobacteriaceae and are inhibited to various degrees by clavulanic acid. The present study is aimed to determine the occurrence and phenotypic detection of Class A carbapenemases in Escherichia coli and Klebsiella pneumoniae blood isolates from septicemic patients. Methods: A total of 75 isolates of K. pneumoniae and 25 E. coli were screened for resistance to carbapenems by using meropenem and imipenem discs and meropenem E-test. Positive strains were then subjected to a modified Hodge test combined with carbapenemase inhibition tests to phenotypically detect and differentiate Class A serine carbapenemases from other classes of carbapenem hydrolyzing enzymes. Results: The screening test showing the number of isolates resistant to meropenem and imipenem were 41 and 35 for K. pneumoniae and nine and four for E. coli, respectively. A total of 25 (33.3%) K. pneumoniae isolates and two (8.0%) E. coli isolates were classified as Class A carbapenemase producers. Multidrug resistance with coexistence of extended spectrum-beta-lactamases occurred in 44.4% isolates. However, all of the isolates were susceptible to colistin, polymyxin B, and tigecycline by disc diffusion test. Conclusion: We conclude from the present study that Class A carbapenemases appear to be the predominant cause of resistance to carbapenems in Enterobacteriaceae at our center and, thus, phenotypic detection based on simple methods should be employed routinely in clinical microbiology laboratories.
机译:对碳青霉烯类药物的耐药性是重大的治疗威胁。革兰氏阴性杆菌中车碳青霉烯酶的频率越来越高,使得它们的早期发现和分化变得迫在眉睫。属于A类的碳青霉烯酶最常由肠杆菌科成员产生,并被棒酸抑制到不同程度。本研究旨在确定败血病患者大肠杆菌和肺炎克雷伯菌血液分离物中A类碳青霉烯酶的发生和表型检测。方法:使用美洛培南和亚胺培南圆片并通过美洛培南E-检验,共筛选了75株肺炎克雷伯菌和25种大肠杆菌对碳青霉烯的抗药性。然后对阳性菌株进行改良的Hodge试验和碳青霉烯酶抑制试验,以从表型上检测和区分A类丝氨酸碳青霉烯酶与其他类别的碳青霉烯水解酶。结果:筛选试验显示,耐美罗培南和亚胺培南的菌株对肺炎克雷伯菌分别为41和35,对大肠杆菌为9和4。共有25(33.3%)肺炎克雷伯菌分离株和2(8.0%)大肠杆菌分离株被归为A类碳青霉烯酶生产者。在44.4%的分离物中出现了多药耐药性并与广谱β-内酰胺酶共存。但是,通过圆盘扩散试验,所有分离株均对粘菌素,多粘菌素B和替加环素敏感。结论:从本研究中我们得出结论,A类碳青霉烯酶似乎是我们中心肠杆菌科对碳青霉烯类耐药的主要原因,因此,在临床微生物学实验室应常规采用基于简单方法的表型检测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号